1. A Well-Tolerated Regimen of 800 cGy TBI-Fludarabine-Busulfan-ATG for Reliable Engraftment after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia 
Seung-Ah Yahng, Jung-Ho Kim, Young-Woo Jeon, Jae-Ho Yoon, Seung-Hwan Shin, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong-Wook Lee, Woo-Sung Min, Chong-Won Park, Hee-Je Kim 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 1, Pages (January 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence of myeloid (left) and platelet (right) engraftment.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Reconstitution of lymphocyte subsets (CD8+ T cells [CD3+CD8+], CD4+ T cells [CD3+CD4+], CD56+ T cells [CD3−CD56+], and B cells [CD19+]) after TCR haplo-identical HSCT after fractionated 800 cGy TBI-based conditioning regimen with low-dose ATG. Curves represent means ± standard error of the mean.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Cumulative incidence of GVHD by donor graft cell dose. (Left) Incidence of grades II to IV aGVHD according to graft CD8+ T cell dose: ≤ (dotted line) versus > (continuous line) median value of CD8+ (172 cells × 106/kg of recipient body weight). (Right) Incidence of moderate to severe National Institutes of Health cGVHD according to graft CD4+ T cell dose: ≤ (dotted line) versus > (continous line) median value of CD4+ (253 cells × 106/kg of recipient body weight).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
Transplantation outcomes according to disease status: Probability of (A) OS and (B) PFS and cumulative incidence of (C) relapse and (D) NRM. Shown are patients with CR1 (n = 52, continuous line), CR2 (n = 17, dotted line), or relapsed/refractory status (n = 11, dashed line) at the time of transplant.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions